Publications

Title

Author

Year

Quantifying Parameter and Structural Uncertainty of Dynamic Disease Transmission Models Using MCMC: An Application to Rotavirus Vaccination in England and Wales.

Bilcke, J; Chapman, R; ATCHISON, C; Cromer, D; JOHNSON, H; Willem, L; Cox, M; EDMUNDS, WJ; JIT, M;

2015

Medical decision making, (2015).35 5 10.1177/0272989X14566013.

Paths to a malaria vaccine illuminated by parasite genomics.

CONWAY, DJ;

2015

Trends in genetics, (2015).31 2 10.1016/j.tig.2014.12.005.

The impact of childhood vaccines on bacterial carriage in the nasopharynx: a longitudinal study.

BOTTOMLEY, C; BOJANG, A; SMITH, PG; Darboe, O; ANTONIO, M; FOSTER-NYARKO, E; KAMPMANN, B; GREENWOOD, B; D'ALESSANDRO, U; ROCA, A;

2015

Emerging themes in epidemiology, (2015).12 1 10.1186/s12982-014-0022-3.

Pneumococcal conjugate vaccines PREVenar13 and SynflorIX in sequence or alone in high-risk Indigenous infants (PREV-IX_COMBO): protocol of a randomised controlled trial.

Leach, AJ; MULHOLLAND, EK; Santosham, M; Torzillo, PJ; Brown, NJ; McIntyre, P; Smith-Vaughan, H; Skull, S; Balloch, A; Andrews, R; Carapetis, J; McDonnell, J; Krause, V; Morris, PS;

2015

BMJ open, (2015).5 1 10.1136/bmjopen-2014-007247.

Statistical estimation of antibody concentration using multiple dilutions.

Cheung, YB; Xu, Y; Remarque, EJ; MILLIGAN, P;

2015

Journal of immunological methods, (2015).417, 10.1016/j.jim.2015.01.001.

Vaccine-criticism on the internet: new insights based on French-speaking websites.

Ward, JK; Peretti-Watel, P; LARSON, HJ; Raude, J; Verger, P;

2015

Vaccine, (2015).33 8 10.1016/j.vaccine.2014.12.064.

Comparison of two dose and three dose human papillomavirus vaccine schedules: cost effectiveness analysis based on transmission model.

JIT, M; Brisson, M; Laprise, J-F; Choi, YH;

2015

BMJ (Clinical research ed), (2015).350 jan06 10.1136/bmj.g7584.

Continuing effectiveness of serogroup A meningococcal conjugate vaccine, Chad, 2013.

Gamougam, K; Daugla, DM; Toralta, J; Ngadoua, C; Fermon, F; Page, A-L; Djingarey, MH; Caugant, DA; MANIGART, O; Trotter, CL; Stuart, JM; GREENWOOD, BM;

2015

Emerging infectious diseases, (2015).21 1 10.3201/eid2101.140256.

Duration of protection of infant BCG vaccination in Ethnic minority groups in England.

MANGTANI, P; NGUIPDOP-DJOMO, P; KEOGH, R; Abubakar, I; SMITH, PG; RODRIGUES, LC;

2015

46th Union World Conference on Lung Health (2015).

ProVac Global Initiative: a vision shaped by ten years of supporting evidence-based policy decisions.

Jauregui, B; Janusz, CB; CLARK, AD; Sinha, A; Garcia, AG F; Resch, S; Toscano, CM; SANDERSON, C; Andrus, JK;

2014

Vaccine, (2014).33 Sup S1 10.1016/j.vaccine.2014.12.080.